Ending a decades-long wait, the US Food and Drug Administration (FDA) today approved the Amplatzer PFO Occluder device (St. Jude Medical) for recurrent stroke prevention in patients with a patent ...

St. Jude Medical’s stroke-fighting heart occluder picked up FDA approval on Friday. The device had previously been available in the U.S. under a humanitarian device exemption, but was voluntarily ...

Please provide your email address to receive an email when new articles are posted on . St. Jude Medical announced the FDA approved its transcatheter device for occlusion of patent foramen ovale. The ...

It's been a long road for St. Jude Medical ($STJ) with its stroke prevention device, but the company is celebrating a milestone after an FDA panel recommended the ...

Results offer compelling evidence for closure with the AMPLATZER PFO Occluder over conventional medical management alone ST. PAUL, Minn. -- St. Jude Medical, Inc., a medical device company, today ...

Abbott has launched its Amplatzer Tailsman PFO Occlosion System in Europe. The device is designed to treat people with a patent foramen ovale (PFO) who have had a stroke and are at risk of having ...

WASHINGTON, Oct. 31 (UPI) --The U.S. Food and Drug Administration has approved the Amplatzer PFO Occluder device for select patients to reduce their risk of recurrent strokes. The PFO Occluder is a ...

A group of doctors convened by the Food and Drug Administration decided Tuesday that a new St. Jude Medical heart device to prevent strokes appears safe and effective, after more than 13 years of U.S.

Rochester, MN - A case report of a patient who suffered erosion of an Amplatzer septal-occluder device (St Jude Medical) six years after it was implanted, resulting in cardiac tamponade and ...

Because the benefits of patent foramen ovale closure were once in question, physicians remain hesitant about its use in clinical practice. Recent data, however, have confirmed the safety and efficacy ...

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window WASHINGTON -- ...

Ten years ago, my tennis partner suffered a stroke. He was a sixty-year-old at the time, working to move up into the top ten players in his age group. In the country! You could not have found a ...